Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
+44 (0) 203 086 8600 Call us on

Bio3 Research S.r.l - Product Pipeline Review - 2012

328.24

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£328.24

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Company Profile

Country

Global

Published

16 July 2012

Number of Pages

32

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

Global Markets Direct

File Format

PDF

Bio3 Research S.r.l – Product Pipeline Review – 2012 - This pharmaceuticals report, "Bio3 Research S.r.l - Product Pipeline Review - 2012" provides data on the Bio3 Research S.r.ls research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from our proprietary databases, Bio3 Research S.r.ls corporate website, SEC filings, investor presentations and featured press releases, both from Bio3 Research S.r.l and industry-specific third party sources, put together by our team.

Scope

- Bio3 Research S.r.l - Brief Bio3 Research S.r.l overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Bio3 Research S.r.l human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Bio3 Research S.r.l with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Bio3 Research S.r.ls pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Bio3 Research S.r.ls strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Bio3 Research S.r.l in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Bio3 Research S.r.ls R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Bio3 Research S.r.l.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Bio3 Research S.r.l and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Bio3 Research S.r.l; Bio3 Research S.r.l - Key Therapeutics; Bio3 Research S.r.l - Pipeline Overview and Promising Molecules; Bio3 Research S.r.l - News; Bio3 Research S.r.l - Latest Updates; Bio3 Research S.r.l - Pipeline; Bio3 Research S.r.l - Discontinued/Dormant Projects

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£328.24

Change Currency

GBP EURO USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Accessibility
Close

Contrast settings

Text size settings